Pfizer Q2 up 61% to Rs 154.25 crore
Pfizer's total expenses were at Rs 430.63 crore during the period under review as against Rs 407.92 crore, up 5.56 per cent.

Its revenue from operations was at Rs 567.06 crore in the quarter, up 9.10 per cent compared to Rs 519.74 crore in the year-ago quarter, Pfizer said in a BSE filing.
Pfizer's total expenses were at Rs 430.63 crore during the period under review as against Rs 407.92 crore, up 5.56 per cent.
Download ET Markets APP